Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
| Actual shortage: | 212 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2706 (92%) | |
Discontinuation Reports |
299 |
|
| To be discontinued: | 2 (1%) | |
| Discontinued: | 297 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
361 (11%) |
|
Overdue reports |
85 (40%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-NABILONE | 1.0MG | CAPSULE | Resolved | 2025-03-20 | 2025-05-08 | 253153 |
| TEVA-NABILONE | 1.0MG | CAPSULE | Resolved | 2017-03-14 | 2018-09-13 | 2218 |
| TEVA-NABILONE | 0.5MG | CAPSULE | Resolved | 2017-03-14 | 2018-09-13 | 2256 |
| TEVA-NABILONE | 0.25MG | CAPSULE | Resolved | 2017-08-01 | 2018-07-03 | 17899 |
| TEVA-NABILONE | 0.25MG | CAPSULE | Resolved | 2021-11-25 | 2021-12-02 | 149942 |
| TEVA-NABILONE | 0.5MG | CAPSULE | Resolved | 2022-02-17 | 2022-04-21 | 155180 |
| TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2022-12-08 | 2023-01-19 | 177529 |
| TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2020-02-21 | 2020-04-02 | 106916 |
| TEVA-NAPROXEN | 250MG | TABLET | Resolved | 2020-04-03 | 2020-05-08 | 110749 |
| TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2023-07-20 | 2023-07-28 | 199306 |
| TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2023-07-27 | 2023-08-18 | 200203 |
| TEVA-NAPROXEN | 375MG | TABLET | Resolved | 2023-11-09 | 2024-01-11 | 209661 |
| TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2023-11-23 | 2024-01-11 | 211319 |
| TEVA-NAPROXEN | 250MG | TABLET | Resolved | 2023-11-30 | 2024-01-08 | 211970 |
| TEVA-NAPROXEN | 250MG | TABLET | Resolved | 2022-06-30 | 2022-08-19 | 163909 |
| TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2022-11-14 | 2023-01-19 | 174583 |
| TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2024-02-01 | 2024-04-25 | 218123 |
| TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2024-02-01 | 2024-05-09 | 218126 |
| TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2024-05-16 | 2024-06-13 | 228140 |
| TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2024-12-19 | 2025-02-28 | 246095 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64612 |
| TEVA-AZITHROMYCIN | 250MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255821 |
| TEVA-CARBAMAZEPINE | 200MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14052 |
| TEVA-CEPHALEXIN | 500MG | CAPSULE | Discontinued | 2020-10-08 | 2020-10-09 | 125979 |
| TEVA-CEPHALEXIN | 250MG | TABLET | Discontinued | 2020-10-08 | 2020-10-09 | 125982 |
| TEVA-CIPROFLOXACIN | 500MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14049 |
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| TEVA-CLARITHROMYCIN | 250MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117529 |
| TEVA-CLARITHROMYCIN | 500MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117526 |
| TEVA-CLOBETASOL | 0.05% | LOTION | Discontinued | 2025-04-25 | 2025-04-25 | 255815 |
| TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64923 |
| TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64926 |
| TEVA-CLONAZEPAM | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64929 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-25 | 2019-10-26 | 97248 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-31 | 2019-11-01 | 97589 |
| TEVA-DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103796 |